Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Gaurav Shah

CEO at Rocket Pharmaceuticals, Inc. (RCKT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $286K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 20SEC RCKTRocket Pharmaceuticals, Inc. Sell 2,2931,056,594 held (−0%) $3.38 $8K -24.3%
Aug 17SEC RCKTRocket Pharmaceuticals, Inc. Sell 2,8371,058,887 held (−0%) $3.38 $10K -24.3%
May 26SEC RCKTRocket Pharmaceuticals, Inc. Sell 55,6841,061,724 held (−5%) $3.09 $172K -17.2%
May 21SEC RCKTRocket Pharmaceuticals, Inc. Sell 2,4091,040,918 held (−0%) $3.01 $7K -15.0%
May 14SEC RCKTRocket Pharmaceuticals, Inc. Sell 2,7281,043,327 held (−0%) $3.61 $10K -29.1%
Feb 20SEC RCKTRocket Pharmaceuticals, Inc. Sell 5,9901,046,055 held (−1%) $3.34 $20K -23.4%
Feb 18SEC RCKTRocket Pharmaceuticals, Inc. Sell 12,2791,052,045 held (−1%) $3.31 $41K -22.7%
Nov 20SEC RCKTRocket Pharmaceuticals, Inc. Sell 6,276778,296 held (−1%) $2.98 $19K -14.1%